Clinical Trials
9 trialsNCT02542124 2018-11-16
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)
Neumedicines Inc.
Phase 2 Unknown
NCT02544724 2016-08-03
NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy
Neumedicines Inc.
Phase 2 Unknown
NCT00003210 2015-04-15
Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003107 2014-09-10
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Indiana University
Phase 1 Completed
NCT00026182 2013-08-26
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003575 2013-02-08
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003451 2013-02-01
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00052377 2013-01-16
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT00004260 2011-08-03
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Mayo Clinic
Phase 1 Completed